Immunohistochemistry confirmed that increased KPNA2 protein expression was presented in yolk sac tumors, immature teratomas, dysgerminomas, embryonal carcinomas, and mixed ovarian germ cell tumors, whereas negative KPNA2 expression was observed in all normal ovarian specimens. This evidence concerns the gene KPNA2 and teratoma.